ATP-生物荧光体外抗肿瘤药物敏感性检测方法的应用探讨
摘要
目的:探讨ATP-生物荧光体外抗肿瘤药物敏感性检测方法的可行性和准确性。方法:通过开展ATP-生物荧光体外抗肿瘤药物敏感性检测的117例标本的肿瘤细胞提取培养、细胞学鉴定及药物敏感性检测结果进行分析,为以后开展该项检测提供技术依据。结果:组织标本和浆膜腔积液标本在体外均可分离培养出肿瘤细胞,ATP-生物荧光体外抗肿瘤药物敏感性检测方法可行,结果准确,有较高的临床符合率。结论:开展ATP-生物荧光体外抗肿瘤药物敏感性检测对临床治疗用药具有重要的指导意义。
出处
《中国民族民间医药》
2013年第23期28-29,31,共3页
Chinese Journal of Ethnomedicine and Ethnopharmacy
参考文献6
-
1Kurbacher CM,Cree IA,Bruckner HW,et al. Use of an ex vivo ATP lu-minescence assay to direct chemotherapy for recurrent ovarian cancer [ J ]. Anti-cancer Drugs, 1998, 38 (9) : 51 -57.
-
2Kurbacher CM, Grecu OM, Stier U , et ai. ATP chemosensitivity testing inovarian and breast cancer : early clinical trials [ J ]. Recent Results Cancer Res,2003, 161 (1) : 221 -30.
-
3Kawano K. The experiment and clinical evaluation of chemosensitivity test foresophageal and gastric cancer by ATP assay using endoscopic biopsy [ J]. NipponGeka Gakkai Zasshi,1992, 93 (2) ; 232-240.
-
4Fehm T, Zwimer M,Wallwiener D, et al. Antitumor activity of zoledronicacid in primary breast cancer cells determined by the ATP tumor chemosensitivityassay [ J]. BMC Cancer, 2012, 23 (12): 308.
-
5Ian A Cree, Christian M, Kurbacher, et al. Correlation of the clinical re-sponse to chemotherapy in breast cancer with ex vivo chemosensitivity [ J] . Anti -cancer Drug, 1996,34 (7): 630 -635.
-
6Knight LA, Kurbacher CM, Glaysher S, et ai. Activity of mevalonate path-way inhibitors against breast and ovarian cancers in the ATP - based tumour chemo-sensitivity assay [J]. BMC Cancer, 2009, 28 (9): 38.
-
1孟凡虹,包群,陆信.人胰腺癌体外抗肿瘤药物敏感性分析研究[J].昆明医学院学报,1993,14(1):8-10.
-
2张伟.生物荧光肿瘤体外药敏检测技术的临床应用[J].中华检验医学杂志,2005,28(12):1316-1319. 被引量:9
-
3王睿.抗生素后效应的方法学研究进展[J].四川生理科学杂志,1997,19(3):42-42. 被引量:1
-
4血药浓度监测[J].中国医学文摘(检验与临床),2007,21(3):191-191.
-
5王胤颖,刘聪艳,张维,贺景娟,苏力,孙婉玲.三磷酸腺苷生物荧光法在急性髓系白血病细胞体外药物敏感性检测的初步应用[J].中国药物警戒,2016,13(3):132-137. 被引量:1
-
6曹新生,鲁文丽.斑贴试验筛查抗结核药物致敏原的探讨[J].护士进修杂志,2000,15(8):574-575. 被引量:1
-
7朱严冰,周桂芬,仉海英.康赛宁治疗恶性浆膜腔积液的临床观察[J].医药导报,1996,15(5):270-271.
-
8李山河.喹诺酮类药物在我院应用现状与分析[J].海峡药学,2016,28(4):239-240.
-
9王传捷,徐小红.593例泌尿生殖道支原体感染及耐药性分析[J].检验医学与临床,2010,7(16):1753-1754. 被引量:5
-
102. Materials and methods 2.1. Materials[J].Journal of Chinese Pharmaceutical Sciences,2013,22(3):252-258.